This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oregon Health & Science University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Willscott Naugler: Innovator in Hepatic Research
Introduction
Willscott Naugler is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of hepatic research, particularly in the normalization of bile acid production. His innovative work has implications for understanding liver function and its associated disorders.
Latest Patents
Naugler holds a patent titled "Normalization of the enterohepatic circulation in animals with a chimeric humanized liver." This patent discloses methods for normalizing bile acid production in a mouse engrafted with human hepatocytes through the administration of human FGF19. Additionally, it describes a transgenic host animal, such as a mouse, that expresses human FGF19, which has normalized bile acid production when engrafted with human hepatocytes. He has 1 patent to his name.
Career Highlights
Naugler is affiliated with Oregon Health & Science University, where he conducts his research. His work is pivotal in advancing the understanding of liver function and its therapeutic applications.
Collaborations
One of his notable collaborators is Markus Grompe, with whom he has worked on various research projects related to liver function and regeneration.
Conclusion
Willscott Naugler's contributions to hepatic research through his innovative patent and collaboration with esteemed colleagues highlight his role as a key figure in the field. His work continues to pave the way for advancements in liver health and treatment options.